Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer.

Article Details

Citation

Copy to clipboard

Anassi E, Ndefo UA

Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer.

P T. 2011 Apr;36(4):197-202.

PubMed ID

21572775 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Sipuleucel-T